DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Flavokavain B
Flavokavain B
(12) United States Patent (10) Patent No.: US 9.421,180 B2 Zielinski Et Al
Herbal Insomnia Medications That Target Gabaergic Systems: a Review of the Psychopharmacological Evidence
Phytochem Referenzsubstanzen
Piper Methysticum)
From Alpinia Zerumbet: Its Isolation, Synthesis, and Characterization
Herbal Insomnia Medications That Target Gabaergic Systems: a Review of the Psychopharmacological Evidence
Evaluating the Chemical Diversity and Biological Activity of Plant Extracts for Commercialization
Kava: a Review of the Safety of Traditional and Recreational Beverage Consumption
Biological Activity, Hepatotoxicity, and Structure-Activity Relationship Of
Kavalactones and Flavokavains in Piper Methysticum (Kava)
The Biosynthetic Origin of Psychoactive Kavalactones in Kava
Activity and Mechanism of Flavokawain a in Inhibiting P‑Glycoprotein Expression in Paclitaxel Resistance of Lung Cancer
(12) Patent Application Publication (10) Pub. No.: US 2005/0037025A1 GOW Et Al
Dietary Chalcones with Chemopreventive and Chemotherapeutic Potential
Reference Substances 2018/2019
Identification, Analysis and Manipulation of the Torrubiellone a Gene Cluster
Reference Substances
Showman, Chemical and Microbial Ecology of 'Awa, Piper Methysticum
Top View
AOAC SMPR® 2018.005 Standard Method Performance Requirements
(12) Patent Application Publication (10) Pub. No.: US 2003/0099756A1 GOW Et Al
WO 2013/049507 Al O
Herbal Contraindications & Drug Interactions
In Vitro Studies of the Hepatotoxic and Hepatoprotective Potential and Metabolism of Chalcones and a Tacrine-Silibinin Codrug
Compositions for Treating Breast Cancer
Drug Interactions with Herbal Medicines
Piper Methysticum G
Kava As a Clinical Nutrient: Promises and Challenges
A UHPLC-UV Method Development and Validation for Determining Kavalactones and Flavokavains in Piper Methysticum (Kava)